Fayetteville State University

DigitalCommons@Fayetteville State University
Math and Computer Science Faculty Working
Papers

Math and Computer Science

Summer 2010

Mathematical Modeling and Simulation of Latency Phase HIV-1
Dynamics
Frank Nani
Fayetteville State University, fnani@uncfsu.edu

Mingxian Jin
Fayetteville State University, mjin@uncfsu.edu

Follow this and additional works at: https://digitalcommons.uncfsu.edu/macsc_wp

Recommended Citation
Nani, Frank and Jin, Mingxian, "Mathematical Modeling and Simulation of Latency Phase HIV-1 Dynamics"
(2010). Math and Computer Science Faculty Working Papers. 21.
https://digitalcommons.uncfsu.edu/macsc_wp/21

This Conference Proceeding is brought to you for free and open access by the Math and Computer Science at
DigitalCommons@Fayetteville State University. It has been accepted for inclusion in Math and Computer Science
Faculty Working Papers by an authorized administrator of DigitalCommons@Fayetteville State University. For more
information, please contact dballar5@uncfsu.edu.

Int'l Cont. Bioinfonnatics and Computational Biology I BIOCOMP'10

428

Mathematical Modeling and Simulation of
Latency Phase HIV-l Dynamics
Frank Nani and Mingxian J in
Department of Mathematics and Computer Science
Fayetteville State University
Fayettev ille, NC 283 01 , USA

Abstract - In this paper, the parho-physiological dynamics
of HlV-/ induced AIDS is analyzed using Q system oj
deterministic ordinary differential equations. The
mathematical model exhibits explicitly the dynamics of the

HlV-J virions during latency phase in the absence of
anti-viral therapy. The model presented in this paper is a
generalization of previous models of HlV-J dynamics and
incorporales Ihe interactions between the HIV- J virions,
infected helper T-Iymphocytes.
uninfected helper
r-Iymphocytes, and cytotoxic T-Iymphocytes, as well as
COn/ributions to HIV-J reservoirs. Investigative compuler
simulations using clinically plausible parametric
configurations are presenled. Clinically relevant criteria
are derived depicting the annihilation, cOn/rol, or
persistence of HIV-J in Ihe absence ofanli-virallherapy.
Keywords: HIV-I dynam ics, mathematical modeling,
model simulation

1. Introduction
The dynamics of HIV-I infection may be divided into
three phases: the initial (pre-latency) phase called primary
HI V- I infection; the latency phase, and the post Imency
phase. During the pre-latency phase, the HI V- I virions
present in the infecting inoculums replicate in the host
(CD4+) T lymphocytes, producing a viremia wh ich elicits
immune response due to viral antigen-presentation action by
the monocytic phagocytic system (MPS) of macro phages.
The initial infection leads to transient infection
resembling mononucleosis for 1-1 2 weeks after exposure
[2,3]. Although symptomatic primary HI V-l infection is
usually characterized by fever, lymphadenopathy,
pharyngitis, arthralgia, rash, and lethargy, many infected
ind ividuals have no such acute phase of HIV infection.
Studies have shown that during symptomatic primary HIV-I
infection, the levels of infecting virions and of infected
helper T cells are very high in the range of 1,000- 10,000
TCIDlpJ of phase [2, 3].
The second phase of HI V- I infection is called the
latency phase. During this phase, the patient undergoes a
drastic reduction in HIV-I viremia and the amount of viral
antigen in most but not all patients [5]. During this phase,

the infected patient is asymptomatic and shows no sign of
fully blown AIDS. The proportion of cells carrying HI V-J
DNA is higher in the lymph nodes than in the peripheral
blood [10]. HIV- l viral replication occurs throughout the
asymptomatic phase, but the function of susceptible cells
that are producti vely infected at any given time is low. The
CDS+ cytotoxic T lymphocytes mediate the destruction of
in fected HI V- l T cells [13, 16]. However, some infected
CD4+ helper cells serve as the host or laboratory for the
production of the HIV-I virions [\9]. Using protease
enzymes and the retro-virus called reverse transcriptase and
resources of the host CD4+ T-lymphocytes, the HIV virions
are assembled into pro-virus equipped with the glycoprotein
gpl20 and gp4l. The newly assembled HIV-I virions are
released into the blood plasma by the process called budding.
This rate is curtailed during the asymptomatic phase.
The third phase of H1V- 1 dynamics is determined by
increase in plasma HIV-l virions and down-regulation of
the CDS+ T-lymphocytes responses. In particular, the CD4+
T-lymphocytes infection increases. There is also re lease of
HIV- I virions from the reservoirs such as the lymphoid
organs, microglial cells of the brain and other sources [1 4,
18J.
Many determ inistic mathematical models of HIV- I
patho-physiodynamics have been constructed in the last few
years. The models incorporate the HIV-I interaction with
the Helper CD4+ T-Iymphocytes and the Cytotoxic CDS+
T-Iymphocytes. Such models include those by Pantaleo el
al.[ I0], Essunger and Perelson [4], Perelson et al. [II ],
Kirschner and Webb [7], Wodarz et al. [ IS, 19]. There have
been stochastic mathematical models of HIV-I dynam ics,
such as the model by Tackwell and Le Corfec [IS}. Han and
Perelson [6] have been involved in the construction of
HIV-I stochastic models for the compUiation and estimation
of HIV - I interaction coefficients.
In this paper, new mathematical mode ls for the
asymptotical latency phase are proposed and analyzed. In
particular, elaborate and robust mathematical criteria will be
derived depicting the conditions under which the latency
period can be maintained indefinitely.
The major contribution of the current research is the
fonnulation of robust criteria under which the HIV-I virions
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will be annihilated or kept under a chronic asymptomatic
latency phase in the absence of anti-HIV-1 drug therapy.
This paper is organized into five sections. Section 2
provides definitions of parameters that are used in the model
equations. Section 3 discusses the model equations and
necessary criteria for the existence of the equilibrium points
or disease outcomes during the latency phase. Section 4
presents computer simulation results and associated graphs.
Section 5 gives a summary.

2. Parameters
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3. Dynamics of HIV-I during latency
phase
In the latency phase, the HIV -I patho-physiodynamics
equations reduce to
btx

XI '" SI + o lx l' e - , -alxlxJ

-qIX'X l

b
Xl '" S1 +olx1x,e - ,., + a lxlx j

- klx l -elO

q1X IX 1 -

-

k 1x 2 -

PIX ] -

K,x, x. -ero

Xl == Sl + P 1X1XJ + PJX J - a j x 1x 3 -k1x1 -e10

X. == S. + o. x,x.e ....·>' - K 2x 1X. -k.X 4 -e.o
X,(II)==X,L
for i== {1, 2,3,4}

(3 .1)

A number of parameters, constants will be used in the
model. We define them as follow.
XI:

X2:

the number density of un-infected CD4 ~ helper
T-lymphocytes per unit volume

C J '= Sup

the number density of HI V- I infected CD4+ helper
T-lymphocytes per unit volume

C l = Sup

X) :

the number density of HI V-I virions in the blood plasma
per unit volume

X4:

the number density of HIV-1 specific CDS+ cytotoxic
T-lymphocytes per unit volume

SI: rate of supply of un-infected CD4+ T4-lymphocytes

S2: rate of supply oflatency infected CD4+ T 4-lymphocytes
S3: rate of supply of HIV- J virions from macrophage,
monocytes, microglial cells and other lymphoid tissue
different from T4-lymphocytes

S4: rate of supply ofCDS+ Ts-lymphocytes from the thymus
a" h;: constant associated with activation of lymphocytes by
cytokine interleukin-2 (IL-2)
a j: constant associated with HIV-l infection of CD4+ T4
helper cells

A

Lei

replication and "budding"
of HIV-I in syncytia CD4+ T4 helper cells per day per
micro liter (Ill) and released into the blood plasma

h X
jX ,X je- / ,

I"(IL.I ~ )

[,B 2X2 X3

+

J

for j'= {J,2,4}

P 3X3 ]

(3.2)

1~ [I J_h l

Where IL is the time at which the latency phase begins.
Similarly,lp is the time at which the post latency phase of
HIV-I dynamics commences in a patient.
The system of differential equations (3.1) red uce to the
following differential inequalities, for f E [ /l.o Ip]:

~

I

+ C I + C 2
S 3 + C J

-
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-k4X 4
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XJ
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1
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=
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)
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)

L

k

I

X 2

x .:::;

the number of HI V-I virions produced per day by
replication and budding in CD4+ T4 helper cells

/h.: rate constant associated with

la

X 4 (t1. )

=

4

I X 1

k

1

x

e

-
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k JX J
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40

x"
X

2 I.

x

J I.

(3.3)

x"

Using the Kamke comparison technique [S], the
differential inequalities lead to the fol lowing theorem .
Theol"em

fl:, . the number of HIV-I virions produced per day by
replication and " budding" in non-syncytia CD4+ T4
helper cells and released into the blood plasma

Lei

qi: constant depicting competition between infected and
un-infected CD4 ~ T4 helper cells

(3.4)

k;: constant depicting degradation, loss of clonogenicity or
"death"

Consider the set

e.o: constant depicting death or degradation or remova l by
apoptosis (programmed cell death)

Ki : constant associated with the kil ling rate of infected CD4-+
T4 cells by CDS+ Ts cytotoxic lymphocytes

A=

kx

l ,

X 2 ' Xl' X 4 ) E

91 ~

10: ; X i < m ; }

Then all solutions of the initial value problem (3 .1) that
originally in int9i'+4 will eventually enter the set of A, such
that the solution will be non-negative, ultimately bounded
and remain in A for alit E 91,.
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(i) If kJ + a]L I -fJ2>0 then as

Proof
The differential inequalities (3.3) can be used to oblairl
the followin g expressions:
X, ::;;

where

Si+C,-e ;o

k,

(1' ,0 E

+a

limSupx 3 (t) =

t

~ 00,

S - e
J

30

kJ + a l L I -

/32

-k ,1
i Oe

In this case, the HIV-l virions population does not
increase but tend to a constant gro\Vth profile. This effect
has been demonstrated in vivo by Chun et al [ Jl-

91- and i= {I , 2 , 3, 4}

-fJ2<

°

Hence. fori = {l , 2, 3,4},

(ii) If kJ +a)~

.
S + C-e
11m Sup Xi(t) = '
k'
iO

virions population becomcs exponential with time, and the
patient will now be in the post-latency phase of viral growth
dynamics and will develop fully-blown AIDS disease.

,

and

x,(t)

E

Sup
A

{

X ;o.

SI +CI -e ,0 }
ki

3.1 Criteria for permanency of latency phase
In this section, the criteria for the permanency of the
latency phase will be derived.
The differential equation for the HIV-J
physiodynamics during the latency phase is :

+

P2Xl - a J x1x 1 - k 1x

1 -

L, =

Sup

X I

the HIV-J

disease

The clinically significant outcomes of HI V-I dynam ics
can obtained as follow. The outcomes are called equilibrium
points or sturdy states which are associated with the model
equations. There are five most clinically interesting
outcomes labeled {E,: i - 1,2,3,4, 5} .
(i) EI .. [0, 0, 0, 0]: this represents the case in which
uninfected CD4 ~ T cells, infected CD4+ T cells, HIV-J
virions in blood plasma, and HIV-J specific CD8+ T cells
are all destroyed. This leads to the immune system paralysis
in which the patient dies of opportunistic bacteria or viral
infection. This case is clinically feasible if Si - e jO =0.

pathoe 10

where S3 is the reflux and repopulation rate of the plasma
HIV-J virions from the lymphoid tissue, microgial cells,
reticules-endothelial cells, monocyteslmacrophages and
other sanctuaries. e 30 is a constant degradation rate of HIV-l
virions. fh. is the "budding" rate constant of HI V-I virions.
Lot

00 ,

3.2 Clinically significant HIV-l
outcomes during latency phase

Thus the flow associated with the system (3.1) is
dissipative, and non-negati ve if Si +C; - eiO > 0, and
eventually enter the set A and remains trapped in A for t E 91',
ifxiOE int9i'_4,
0

x 1 (t) = SJ

and then as t ~

(ii) E2 = [Xl ' 0, 0, X4 ] : this represents the case in which
infected CD4+ T cells and HIV-l virions in blood plasma are
all destroyed. Clinical doctors working with HIV-l infected
patients would like to achieve this outcome. This
equilibrium point is clinically possible Wlder the following
necessary conditions:

(t )

(3 .5)
and

S J -eJo;:: O,

then

and

where k is a positive constant.

(iii) E3 "'" [0, X2'

x3 ' 01: this depicts a cl inically worst case

situation in which both uninfected CD4 ~ T cells and HIV-I
specific CDS'" T cells are destroyed. This equilibrium point
is clinically possible under the following necessary
conditions:

(3 .6)

In particular, the following scenarios arise:
(iv) £4 = [XI' 0, 0, 0]: this is the most clinically desirable
equilibrium point in which infected CD4+ T cells, plasma
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HIV- I virions, and HIV-I specific cytotoxic CD8+ T cells
are all annihilated. The necessary conditions for the
existence of this equilibrium point are:
S) + a)xl~e - bli"

I

S 2 -

e 20

-

-

klx l -

(v)

= 0

0

S 3 - e 30 = 0

S4-e 40

e 10

(3 .7)

=0

Es= [X I ,X 2 , X3 ,X 4 ]: this case can only exist if the

equation (3.0) exhibits persistence in which all the four
factors co-exist. The details of showing persistence in
nonlinear systems of differential equations have been
discussed by Nani and Freedman in [8].

I
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simulations, as shown in Figure I and Figure 2. Other
simulation results will be published in future papers. In
Figure I, it can be observed that the HI V-I virions (X3) is
restricted to a relatively long latency period, due to effective
cyto lytic action of the CD8+ cytotoxic T cells (X4) . In Figure
2, it can be seen that HIV- J virions undergo a relatively
short latency period and then replicate rapidly in the
presence of non-effective cytolytic action of CD8+
cytotoxic T cells (X4) . The difference between the two
simulation results can be accounted for by non-zero value of
S3 which depicts HI V- I virions released from all viral
reservoirs [12, 17].
Based on the above simulation results, we have the
following observations:
(i) Both the un-infected CD41" T cells and HIV- J specific
CD8+ T cells survive during the latency phase.

There are other equ ilibrium points such as E[xt, X2, 0, 0],
E [0, 0,
'4] and many planar or axial points. These are
clinical unfeasible and are not considered in this paper, but
will be analyzed in a future paper.

(ii) The infected CD4+ T cells and the plasma HIV-I virion
concentration are comp letely annihilated .

4. Simulation results and discussion

(iii) The patient will be in the chronic asymptomatic HIV-l
infection state. The disease configuration is £ 2"" [ XI ' 0,

X"

In this section, investigative computer simulations are
perfonned under specific parametric configurations. The
model data values shown in Table I and Table 2 are
compatible with the data values used in the literatures [4, 7,
15, 17]. It should be noted that it is virtually impossible to
get all values for a particular HIV-I infected patient [20].
The time scale used in the hypothetical simulations is
nonnalized in years. We only present two scenarios of the

0,

.\-4 J.

(iv) In order for the patient to continue to be in the latency
phase the necessary conditions (3 .5) must be
maintained in addition to certain sufficiency conditions
obtained by either using Liapunov functions for global
stability or using unifonn persistence criteria (see [ 8]).

Table I Parametric Configuration
I.S /day/pi
0.009 /day/cell/pi
b1 = 0.00J /cell/pi
0: 1 = O.OS/day/virion/pi
kl = O.OOS/day/pi
ql = 0.0045/day/pJ/cell
elO = 8.8 cells/day/pi
X II. = 703 cells/pi
SI -

a) =

0.85 /day/pi
= 0.004 /day/celVpi
b2 = 0.004/ce\llpi
0:2= O. lIday/virioni pi
k2 = O.05/day/pi
q2 = O.OOOl /day/pi/cell
f3t = 50 virons/CD4+/day
KI = O.OOI /day/pi
e20 = 0.005 cells/day/.uI
X21. = 100 celis/pi
S2-

a2

~

S3 - 0.0 /day/pi
fJ2 = 0 virons/CD4 ~/day/.uI
f3J = 50 vironS/CD4+/day
0:3 == O.0027/day/virionlpi
k 3 = 0.000 IIday
e30 = 0.0001 /day
X31. = 0.01 cells/.uI

S4 - 0.272 /day/pl
a4 = 0.0075 /day/celll.ul
b4 = O.OOI /cell/,ul
K2 = 0.0024 /day/pi
k4 = O.OOI /day/pi
e40 = 7.75 cells/day/pi
X41. = 800 cells/pi
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Table 2 Parametric Configuration P1
SI - J.5 /day/pJ
01 = 0.009 /day /celV,ul
hi == O.OOI/cell/pi
at = O.05/day/virionipJ
kl = O.OOS/day/J.d
q1 =O.0045/day/,uVceli
CIO = 8.8 cells/day/pi
XlL = 703 cel ls/pI

S, - 0.85 /day/pI
a2 = 0.004 /day/ccIV,ul
b2 = O.004/cell/.uJ

O. I/day/virion!pi
k2 = O.OS/day/pi
q2 = O.OOOl /day/,ulIcel l

a2=

PI = 51 vironsJCD4+/day
Kl = O.OO I /day/pi
ezo '" 0.005 celts/day/pi
Xu =

S, - 10.5 /day/pI
p, - 0.025

S4 - 0.272 /day/pl
a4 == O.OO7S /day/ceIV,u1
b4 == 0.00 IIcell/,ul

vironsJCD4+/dayl,ul

/3; = 51 virons/CD4+/day
a] = O.027/day/virionl,ul

Kl = 0.0024 /day/pJ
k4 = O.08/dayl,ul
e 40 = 10.75 cells/day/.uJ
X 4L = 800 cells!,uI

kJ = O.OOO I/day
= 0.000 I Iday
Xn = 5.5 cells/pi
eJO

200 cells/pI

x,

X,
10000

300

8000

250
200

6000

/"

4000

150

JOO

/

2000
0
0

50

,

0
4

6

8
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0

4

,3

8

JO

8

JO

X,

JO

10000

8

8000

6

6000

4

4000

,

2000

0

0

-,

6

0

/
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/
0

2

4

Figure 1 Simulation results using parametric configuration PI
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Figure 2 Simulation results using parametric configuration

5. Summarizing remarks
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